Date published: 2025-9-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

neuroligin 2 Activators

The chemical class termed neuroligin 2 activators comprises a diverse array of compounds with distinct mechanisms of action converging on the modulation of NLGN2 expression. These compounds, ranging from lithium chloride to tranylcypromine, exert their effects through intricate cellular pathways. For instance, lithium chloride and its analog, lithium bromide, target the Wnt/β-catenin signaling pathway by inhibiting glycogen synthase kinase-3 beta (GSK-3β). This inhibition stabilizes β-catenin, allowing it to translocate into the nucleus and participate in the transcriptional activation of NLGN2. Forskolin, a potent adenylate cyclase activator, enhances NLGN2 expression through cAMP/PKA/CREB signaling. Similarly, valproic acid and trichostatin A, both histone deacetylase inhibitors, epigenetically regulate NLGN2 gene expression by promoting histone hyperacetylation, creating a permissive chromatin environment. Retinoic acid and its isomer 9-cis-retinoic acid function as ligands for retinoic acid receptors, forming complexes that bind to retinoic acid response elements in the NLGN2 promoter, driving transcription.

Compounds like bicuculline and A23187 indirectly activate NLGN2 by modulating GABAergic signaling and elevating intracellular calcium levels, respectively. Sodium butyrate, another HDAC inhibitor, supports NLGN2 expression by preventing histone deacetylation. SKF-96365 disrupts calcium signaling, potentially impacting pathways related to NLGN2 expression. Tranylcypromine, a monoamine oxidase inhibitor, influences NLGN2 through intricate interactions within the neuronal network, altering monoamine neurotransmitter levels. In summary, the neuroligin 2 activators class encompasses compounds with diverse molecular targets, including signaling pathways, epigenetic regulation, and neurotransmitter systems. Their collective influence on NLGN2 expression highlights the complexity of cellular regulation and provides a nuanced understanding of the mechanisms driving the modulation of this important synaptic adhesion molecule.

SEE ALSO...

Items 11 to 11 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Tranylcypromine

13492-01-8sc-200572
sc-200572A
1 g
5 g
$172.00
$587.00
5
(1)

Tranylcypromine is a monoamine oxidase inhibitor, affecting monoamine neurotransmitter levels. Altered monoamine levels can activate downstream signaling pathways, potentially influencing the expression of NLGN2 in neurons through intricate interactions within the neuronal network.